Table 2

Outcome measures used in the five cohorts (mean±SD)

Belgian cohort (n=242)US cohort 1 (n=243)US cohort 2 (n=159)Swedish cohort 1 (n=353)Swedish cohort 2 (n=147)
Pain/discomfort threshold (mm Hg)10±426±1316±833±1327±8.8
GI symptoms
 IBS-SSS275±91284±92304±90315±91
 GSRS-IBS3.5±0.95
 DSS14±5
Non-GI symptoms
 SCL-90 som0.89±0.71
 PHQ-128.9±4.27.4±4.08.5±4.1
 RPSQ11±5.211±5.4
Anxiety
 HAD6.2±4.17.7±4.68.5±4.6
 BSI-1852±1151±9.7
Depression
 HAD4.4±3.75.1±3.75.3±3.5
 BSI-1852±9.953±11
  • The sensitivity parameters are displayed as thresholds in mm Hg above the operating pressure for all cohorts except for Swedish cohort 2, as this distension protocol started from 0 mm Hg, whereas all the others distension protocols started from the operating pressure.

  • Empty cells indicate that this variable was not used in the cohort.

  • BSI-18, Brief Symptom Inventory-18; DSS, Dyspepsia Symptom Severity Scale; GSRS-IBS, Gastrointestinal Symptom Rating Scale-IBS;  HAD, Hospital Anxiety and Depression Scale; IBS-SSS, IBS-Severity Scoring System; PHQ-12, Patient Health Questionnaire 12; RPSQ, Recent Physical Symptoms Questionnaire; SCL-90, Symptom Checklist-90; SCL-90 som, SCL-90 somatisation subscale without GI sx.